Skip to main content
SpringerLink
Log in

Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639–1651

    Article  CAS  PubMed  Google Scholar 

  2. DeAngelis LM, Posner JB (2009) Neurologic complications of cancer. Oxford University Press, New York

    Google Scholar 

  3. Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67:323–326

    Article  CAS  PubMed  Google Scholar 

  4. Liu AK, Macy ME, Foreman NK (2009) Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys 75:1148–1154

    Article  CAS  PubMed  Google Scholar 

  5. Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen T (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94:63–68

    Article  CAS  PubMed  Google Scholar 

  6. Wong ET, Huberman M, Lu XQ, Mahadevan A (2008) Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol 26:5649–5650

    Article  PubMed  Google Scholar 

  7. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Prabhu S, Loghin M, Gilbert MR, Jackson EF (2010) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2009.12.061

Download references

Author information

Authors and Affiliations

  1. Hospices Civils de Lyon, Neurologie B, 69394, Lyon, France

    Amandine Benoit, François Ducray, Stéphanie Cartalat-Carel & Jérôme Honnorat

  2. INSERM, U842, Lyon; Université Lyon 1, UMR-S842, Lyon, 69008, France

    François Ducray & Jérôme Honnorat

  3. Service de Neurologie Mazarin, Hôpital de la Salpêtrière, 47, Boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    Dimitri Psimaras

  4. Service de Neurologie, Hôpital du Val-de-Grâce, 74, Boulevard de Port-Royal, 75005, Paris, France

    Damien Ricard

  5. Neurologie B, Hôpital Neurologique de Lyon, 59 Boulevard Pinel, 69677, Bron Cedex, France

    Jérôme Honnorat

Authors
  1. Amandine Benoit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. François Ducray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stéphanie Cartalat-Carel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dimitri Psimaras
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Damien Ricard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jérôme Honnorat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jérôme Honnorat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benoit, A., Ducray, F., Cartalat-Carel, S. et al. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis. J Neurol 258, 328–329 (2011). https://doi.org/10.1007/s00415-010-5747-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5747-5

Keywords

Search

Navigation